The Bahnson Research Group studies Redox Biology in Cardiovascular Disease and the development of targeted nanocarriers to deliver therapeutics.
- Blood and vascular biology
- Cardiovascular disease
- Vascular Smooth Muscle Cell Biology
- Redox Biology
- Targeted drug delivery
The overarching theme of our research program is to understand the role of redox biology in the pathophysiology of cardiovascular disease. We study the redox regulation of vascular smooth muscle phenotypic modulation, redox dysfunction in the endothelium, and redox dysfunction in leukocytes in the context of cardiovascular disease. Armed with that understanding, we aim to develop redox intervention to improve various cardiovascular pathologies including, atherosclerosis, thrombosis, and restensosis. Nanotechnology has the potential to dramatically change the way we administer therapeutics. Under the premise that cardiovascular disease is often localized, we develop nanocarriers for targeted delivery of therapeutics to treat cardiovascular disease.